InMed Pharmaceuticals Inc. (INM) vs Quince Therapeutics, Inc. (QNCX)
A side-by-side comparison of InMed Pharmaceuticals Inc. and Quince Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INM
InMed Pharmaceuticals Inc.
$1.33HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
QNCX
Quince Therapeutics, Inc.
$27.36HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — INM vs QNCX
growth of $100 · dividends reinvested · last 7yINM -100.0% (-69.8%/yr)QNCX -99.6% (-54.1%/yr)QNCX compounded faster over this window
Log scale — wide-divergence pair
INM QNCX
INM vs QNCX: by the numbers
- •QNCX is the larger company ($8M vs $7M market cap).
- •Both run net losses; QNCX's is the smaller (0.00% vs -0.61% net margin).
Metrics side by side
Valuation
| Metric | INM | QNCX |
|---|---|---|
| P/S ratio | 0.00 | N/A |
| P/B ratio | 6.80 | N/A |
Profitability
| Metric | INM | QNCX |
|---|---|---|
| Gross margin | 14.92% | 0.00% |
| Operating margin | -0.52% | 0.00% |
| Net margin | -0.61% | 0.00% |
| ROE | -1168.44% | -85.24% |
| ROIC | -995.44% | -107.08% |
Growth (annualized)
| Metric | INM | QNCX |
|---|---|---|
| Total return CAGR (5Y) | -71.98% | -72.96% |
Frequently asked
- How have INM and QNCX total returns compared?
- Over the past 5 years, INM delivered -71.98% and QNCX delivered -72.96% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.